Answer
For previously untreated chronic lymphocytic leukaemia in adults, Venclyxto (venetoclax) is indicated in combination with acalabrutinib with or without obinutuzumab, obinutuzumab alone, or ibrutinib.
Sources for this answer
- Venclyxto 10mg film-coated tabletsAbbVie Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 25Document updated
Sources checked